Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1424667 | 0.88 | KDM4E (0.53) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL13084305 | 0.80 | ALDH1A1 (0.44) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL9636673 | 0.80 | ALDH1A1 (0.44) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL30209742 | 0.75 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL1716682 | 0.75 | KDM4E (1.00) | KDM4EALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL7408340 | 0.74 | ALDH1A1 (0.51) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL14136412 | 0.73 | ALOX15 (0.61) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL6509907 | 0.72 | ALOX15 (0.67) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL680955 | 0.71 | ALDH1A1 (0.61) | KDM4EALDH1A1ALOX15TSHRHIF1A | |
| SCHEMBL5177578 | 0.71 | ALDH1A1 (0.61) | KDM4EALDH1A1ALOX15TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4874687-A | EXPOSE OF MIXTURE OF SILVER HALIDE EMULSION, HARDENER AND METALLIC SALT; DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-17 | — | — | US | claimed |
| EP-2776412-B1 | PROCESS FOR PREPARING A DIVINYLARENE DIOXIDE | BLUE CUBE IP LLC (US) | 2017-05-03 | — | — | EP | disclosed |
| US-9334252-B2 | Process for preparing a divinylarene dioxide | BLUE CUBE IP LLC (US) | 2016-05-10 | — | — | US | disclosed |
| US-20140256969-A1 | PROCESS FOR PREPARING A DIVINYLARENE DIOXIDE | BLUE CUBE IP LLC | 2014-09-11 | — | — | US | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-8642014-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| WO-2013070392-A1 | PROCESS FOR PREPARING A DIVINYLARENE DIOXIDE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2010-10-21 | — | — | US | disclosed |
| EP-0717079-B1 | Injection molded article for photographic photosensitive material, molding method thereof and package using the same | FUJI PHOTO FILM CO LTD (JP) | 2002-07-24 | — | — | EP | disclosed |
| EP-0569950-A1 | Molded articles for photographic photosensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1993-11-18 | — | — | EP | disclosed |
| EP-0210660-B1 | IMAGE FORMING PROCESS | FUJI PHOTO FILM CO., LTD. (JP) | 1992-05-27 | — | — | EP | disclosed |
| US-4920035-A | Development of silver halide emulsion using complexing compound | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-24 | — | — | US | disclosed |
| US-4880725-A | INTENSIFIED DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-14 | — | — | US | disclosed |
| US-4880723-A | WATER INSOLUBLE AND WATER SOLUBLE SALTS, IMAGES, COMPLEXING | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-14 | — | — | US | disclosed |
| US-4876171-A | REDUCING AGENT, DEVELOPMENT NUCLEUS, AND PICOLINIC ACID SALT-TYPE COMPLEXING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-24 | — | — | US | disclosed |
| US-4874687-A | EXPOSE OF MIXTURE OF SILVER HALIDE EMULSION, HARDENER AND METALLIC SALT; DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-17 | — | — | US | disclosed |
| US-4791048-A | Color image forming process utilizing substantially water-insoluble basic metal compounds and complexing compounds | FUJI PHOTO FILM CO., LTD. (JP) | 1988-12-13 | — | — | US | disclosed |
| US-4740445-A | COMPLEXING METAL COMPOUNDS WITH PYRIDINE OR QUINOLINE RING HAVING AMINE SALT FUNCTION | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0210660-A2 | Image forming process | FUJI PHOTO FILM CO., LTD. (JP) | 1987-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100266507-A1 | LUMINESCENT COMPOUNDS | SQLE, COASY, ZKSCAN2 | KDM4E 1279/4885ALDH1A1 2552/4885ALOX15 2714/4885 |
| US-20140256969-A1 | PROCESS FOR PREPARING A DIVINYLARENE DIOXIDE | HAO2, PPOX, HVCN1 | KDM4E 1701/4885ALDH1A1 2692/4885ALOX15 591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.